Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0YLNPN)
| ADC Name |
BRY-812
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
BRY 812; BRY-812; BRY812
Click to Show/Hide
|
|||||
| Organization |
BioRay Biopharmaceutical Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Zinc transporter ZIP6 (SLC39A6)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Payload Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC
| Indication | Phase 1 | Phase 2 | Phase 3 | Approved | ||
|---|---|---|---|---|---|---|
| Cardiovascular system disease |
1 Trials
|